Hotline:
+ 49 (0) 2204 2918806

Market studies for category Y

7 Item(s)

  1. Net price*
    Year
  2. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    York Pharma Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    38 pages
    York Pharma Plc (York Pharma) together with its subsidiaries is engaged in acquisition, development, and commercialization of prescription dermatological products. It owns a portfolio of novel pharmaceutical products for dermatological conditions, including fungal infections, atopic eczema, irritant contact dermatitis, acne, and psoriasis
    Englisch | Zukunftsanalyse | SKU: 163064
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    33 pages
    Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (YRDC) is a technology transfer company. The company markets the inventions and know-how accomplished by the University's researchers and students. Its intellectual property includes inventions and know-how in many fields, including nanotechnology, medicine and
    Englisch | Zukunftsanalyse | SKU: 339638
  4. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Yamasa Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 pages
    Yamasa Corporation (Yamasa) is a pharmaceutical products manufacturer. The company manufactures pharmaceutical products and soya sauce. It works through two divisions such as diagnostic division and biochemical division. Yamasa’s diagnostic division manufactures diagnostic kits, equipments, and monoclonal antibodies for medical research
    Englisch | Zukunftsanalyse | SKU: 331910
  5. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Yoho Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2013

    GlobalData
    68 pages
    Yoho Resources Inc. (Yoho) is a Canada-based oil and gas exploration company. The company carries out exploration, development and production of crude oil and natural gas liquid, and natural gas. The company has operations within the Western Canadian Sedimentary Basin focusing exploration activity in two areas: West central Alberta and no
    Englisch | Zukunftsanalyse | SKU: 195739
  6. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Yung Shin Pharma Ind. Co. Ltd. (3705) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 pages
    Yung Shin Pharma Ind. Co. Ltd (Yung Shin Pharma) is a pharmaceutical company, based in Taiwan. The company operates through its businesses such as generic medicine, controlling the API supply chain, exploring the global market and health solutions. Its product portfolio includes pharmaceutical preparations such as capsules, granules, inje
    Englisch | Zukunftsanalyse | SKU: 387922
  7. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Yeda Research and Development Company Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    16 pages
    Yeda Research and Development Company Ltd. (Yeda Research) is a technology transfer company. The company markets intellectual property, which is created at the Weizmann Institute laboratories. Its services include identification of projects with commercial potentials, channels funding for the research projects, protecting intellectual pro
    Englisch | Zukunftsanalyse | SKU: 331936
  8. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    YM BioSciences Inc. (YM) - Medical Equipment - Deals and Alliances Profile

    GlobalData
    19 pages
    YM BioSciences Inc. (YM BioSciences) is a life sciences product development company. It focuses on the advancement of three clinical-stage hematology and oncology products, namely, CYT387, nimotuzumab, and CYT997. CYT387 is a small molecule, dual inhibitor of the JAK1/JAK2 kinases, which is currently under Phase I/II trial is meant for th
    Englisch | Zukunftsanalyse | SKU: 330773

7 Item(s)